(Q38046118)

27 August 2017

Differential diagnosis and management of Behçet syndrome (English)

1 reference

27 August 2017

0 references

Nicola L Ambrose

1

0 references

author name string

Dorian O Haskard

series ordinal

2

1 reference

PubMed ID

23007742

27 August 2017

language of work or name

English

0 references

publication date

25 September 2012

1 reference

Nature Reviews Rheumatology

27 August 2017

1 reference

27 August 2017

9

1 reference

27 August 2017

2

1 reference

27 August 2017

79-89

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2012.156

27 August 2017

0 references

cites work

Description of Behçet's syndrome in the Hippocratic third book of endemic diseases

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

A historical review of early descriptions of Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Hereditary periodic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's disease as an autoinflammatory disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behcet's disease in Iran: analysis of 6500 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany -- current pathogenetic concepts and therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Prevalence of Behçet's disease in Istanbul, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behcet's syndrome in 32 patients in Yorkshire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Impact of Behçet's syndrome on health-related quality of life: influence of the type and number of symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

The pustular skin lesions in Behcet's syndrome are not sterile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Uveitis in Behçet disease: an analysis of 880 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

The prevalence of headache in Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Histopathology of central nervous system lesions in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Labyrinthine involvement in Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

The arthritis of Behçet's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

A wider spectrum of spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Gastrointestinal manifestations of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Wireless capsule endoscopy in the investigation of intestinal Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's Syndrome and Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Urologic screening for men with Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

HLA-B*51 and Behçet Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

The pathergy test and Behçet's syndrome in Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Diagnostic value of pathergy test in Behcet's disease according to the change of incidence over the time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Response to intradermal injection of monosodium urate crystals in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

A double-blind trial of depot corticosteroids in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

A double-blind trial of colchicine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

A controlled trial of azathioprine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Mucocutaneous lesions of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Azathioprine in severe uveitis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Azathioprine in Behcet's syndrome: effects on long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Vitamin D endocrine system and the immune response in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a r

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Intravenous immunoglobulin in eye involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Behçet's disease: evaluation of a new instrument to measure clinical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Clinical manifestations of Behçet's disease: an analysis of 2147 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Smoking and Behçet's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Neurological complications in Behçet's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

MRI in neuro-Behçet's syndrome: comparison of conventional spin-echo and FLAIR pulse sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Seven-year follow-up of neurologic involvement in Behçet syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Thrombosis and Behçet's syndrome in non-endemic regions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Atherosclerosis in Behçet's Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Pharmacotherapy for Behcet's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: Cutaneous polyarteritis nodosa and Behçeťs disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Neurological manifestations of Behçet's disease: evaluation of 40 patients treated by cyclophosphamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Long-term outcome after surgical treatment of arterial lesions in Behçet disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Tocilizumab may be a potential addition to our weapons against neuro-Behçet’s disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Tocilizumab treatment for neuro-Behcet's disease, the first report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.156

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

31 March 2020

1 reference

12 December 2020

Neuro-Behçet's disease.

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

[Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease]

1 reference

12 December 2020

The prevalence of Behçet's syndrome in a rural area in northern Turkey

1 reference

12 December 2020

Treatment of endogenous uveitis with cyclosporine A

1 reference

12 December 2020

Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study

1 reference

12 December 2020

WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran.

1 reference

12 December 2020

Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study.

1 reference

12 December 2020

A double blind study of colchicine in Behçet's disease

1 reference

12 December 2020

The menacing pulmonary artery aneurysms of Behçet's syndrome

1 reference

12 December 2020

Fibromyalgia in Behçet's disease is associated with anxiety and depression, and not with disease activity.

1 reference

12 December 2020

Vitamin D status in patients with Behcet's Disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2012.156

1 reference

PubMed ID

23007742

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

23007742